Ansgar Weltermann
Overview
Explore the profile of Ansgar Weltermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Machherndl-Spandl S, Jager E, Barna A, Gurbisz M, Marschon R, Graf T, et al.
Eur J Haematol
. 2021 May;
107(2):265-274.
PMID: 33998054
In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised...
12.
Nikoloudis A, Wagner H, Machherndl-Spandl S, Buxhofer-Ausch V, Strassl I, Stiefel O, et al.
Transplant Cell Ther
. 2021 May;
27(8):686.e1-686.e9.
PMID: 33991724
Although the risk for nonrelapse mortality (NRM) associated with early cytomegalovirus (CMV) reactivation (CMVR) after allogeneic hematopoietic stem cell transplantation (HSCT) is well established, debate is ongoing on whether CMVR...
13.
Geissler K, Jager E, Barna A, Gurbisz M, Graf T, Graf E, et al.
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32344757
Although the RAS-pathway has been implicated as an important driver in the pathogenesis of chronic myelomonocytic leukemia (CMML) a comprehensive study including molecular and functional analyses in patients with progression...
14.
Stuhlinger M, Weltermann A, Staber P, Heintel D, Nosslinger T, Steurer M
Wien Klin Wochenschr
. 2019 Aug;
132(3-4):97-109.
PMID: 31414181
Ibrutinib is the first clinically approved inhibitor of Bruton's tyrosine kinase, an enzyme that is essential for survival and proliferation of B‑cells by activating the B‑cell receptor signalling pathway. Ibrutinib...
15.
Geissler K, Jager E, Barna A, Gurbisz M, Marschon R, Graf T, et al.
Wien Klin Wochenschr
. 2019 Jul;
131(17-18):410-418.
PMID: 31321531
In the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) clinicolaboratory real-life data have been captured from 606 CMML patients from 14 different hospitals over the last 30 years. It is...
16.
Sperr W, Herndlhofer S, Gleixner K, Girschikofsky M, Weltermann A, Machherndl-Spandl S, et al.
Am J Hematol
. 2017 Jul;
92(10):E567-E574.
PMID: 28699225
The aim of this study was to evaluate the efficacy and feasibility of intensified consolidation therapy employing fludarabine and ARA-C in cycle 1 and intermediate-dose ARA-C (IDAC) in cycles 2...
17.
Clausen J, Bohm A, Strassl I, Stiefel O, Buxhofer-Ausch V, Machherndl-Spandl S, et al.
Biomedicines
. 2017 May;
5(2).
PMID: 28536356
Rabbit anti-thymocyte globulins (ATGs) are widely used for the prevention of acute and chronic graft versus host disease (aGVHD, cGVHD) following allogeneic hematopoietic stem cell transplantation (HSCT). However, most prospective...
18.
Sperr W, Zach O, Poll I, Herndlhofer S, Knoebl P, Weltermann A, et al.
Am J Hematol
. 2016 Sep;
91(12):1239-1245.
PMID: 27643573
Although it is generally appreciated that a subset of elderly patients with acute myeloid leukemia (AML) may benefit from intensive consolidation, little is known about variables predicting such benefit. We...
19.
Varghese J, Holz C, Neuhaus P, Bernardi M, Boehm A, Ganser A, et al.
Stud Health Technol Inform
. 2016 Sep;
228:282-6.
PMID: 27577388
Data standards consisting of key data elements for clinical routine and trial documentation harmonize documentation within and across different health care institutions making documentation more efficient and improving scientific data...
20.
Springer A, Hammer J, Winkler E, Track C, Huppert R, Bohm A, et al.
Radiat Oncol
. 2016 Mar;
11:46.
PMID: 27000180
Background: To implement total body irradiation (TBI) using volumetric modulated arc therapy (VMAT). We applied the Varian RapidArc™ software to calculate and optimize the dose distribution. Emphasis was placed on...